Changing the way we do business: Recommendations to accelerate biomarker development in pancreatic cancer.
Clinical Cancer Research.
Times cited: 13
Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement.
Annals of Surgical Oncology.
Times cited: 151